Board # 34: Work in Progress: Year Two of Analysis of the Impact of a Web-based Student Dashboard for a Multi-agent Approach to Academic Advising Dr. Oscar Antonio Perez (University of Texas, El Paso), Dr. Peter Golding (University of Texas, El Paso), Dr. Virgilio Ernesto Gonzalez (University of Texas, El Paso), and Mr. Mike Thomas Pitcher. Multilevel analysis: An introduction to basic and advanced multilevel modeling. London: SAGE Publications Ltd. SPSS for Windows (Version 16.0) Statistical Analysis Program. Chicago: SPSS Inc. SPSS Text Analysis for Windows (Version 16.0) Statistical Analysis Program. Chicago: SPSS Inc. Findings of the study suggested that digital generation student teachers’ use of technology in the classroom was significantly correlated with their self-efficacy, perceived computer skills, and technology access and support. However, the participants’ perceived level of risk taking was not related to their use of technology in the classroom. Becker Public Schools Daily Classroom Blog Rasmussen Staff Development. Students will research historically banned/challenged books. In the process of researching, students will read the selected literary work and to assist in researching the context in which it was banned and/or challenged. Through an analysis of history and social issues.

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the classroom management systems market and it is poised to grow by USD 8.82 bn during 2020-2024, progressing at a CAGR of over 28% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Click & Get Free sample report in minutes

Impact of COVID-19
The COVID-19 pandemic continues to transform the growth of various industries, however, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. COVID-19 will have a low impact on the classroom management systems market. The market growth in 2020 is likely to increase compared to the market growth in 2019.

Frequently Asked Questions:

• What are the major trends in the market?
  An increase in the number of virtual schools is a major trend driving the growth of the market.
• At what rate is the market projected to grow?
  The market will accelerate at a CAGR of over 28% and the incremental growth of the market is anticipated to be $ 8.82 bn.
• Who are the top players in the market?
  APLAF Inc., Blackboard Inc., ClassDojo Inc., Dell Technologies Inc., Faronics Corp., HP Inc., Impero Solutions Ltd., Lenovo Group Ltd., Netop Solutions AS, and NetSupport Ltd., are some of the major market participants.
• What is the key market driver?
  The focus on collaborative learning tools is one of the major factors driving the market.
• How big is the North America market?
  The North America region will contribute to 33% of the market share.

Related Reports on Consumer Discretionary Include:

• K-12 Online Tutoring Market by Type and Geography - Forecast and Analysis 2020-2024- The K-12 online tutoring market size has the potential to grow by USD 80.18 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
  
• Self-paced E-learning Market by Product and Geography - Forecast and Analysis 2020-2024 - The self-paced e-learning market size has the potential to grow by USD 6.71 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. APLAF Inc., Blackboard Inc., ClassDojo Inc., Dell Technologies Inc., Faronics Corp., HP Inc., Impero Solutions Ltd., Lenovo Group Ltd., Netop Solutions AS, and NetSupport Ltd. are some of the major market participants. The focus on collaborative learning tools will offer immense growth opportunities. In a bid to help players strengthen their market foothold, this classroom management systems market forecast report provides a detailed analysis of the leading market vendors. The report also empowers industry honchos with information on the competitive landscape and insights into the different product offerings offered by various companies.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Classroom Management Systems Market 2020-2024: Segmentation

Classroom Management Systems Market is segmented as below:

• Deployment
  • On-premise
  • Cloud-based
• End-user
  • Higher Education
  • K-12
• Geography
  • North America
  • Europe
  • APAC
  • South America
  • MEA

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40640

Classroom Management Systems Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The classroom management systems market report covers the following areas:

• Classroom Management Systems Market Size
• Classroom Management Systems Market Trends
• Classroom Management Systems Market Industry Analysis

This study identifies an increase in the number of virtual schools as one of the prime reasons driving the classroom management systems market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.

Classroom Management Systems Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist classroom management systems market growth during the next five years
• Estimation of the classroom management systems market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the classroom management systems market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of classroom management systems market vendors

Table of Contents:

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

• Five Forces Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by End-user

• Market segments
• Comparison by End user placement
• Higher education - Market size and forecast 2019-2024
• K-12 - Market size and forecast 2019-2024
• Market opportunity by End user

Market Segmentation by Deployment

• Market segments
• Comparison by Deployment placement
• On-premise deployment - Market size and forecast 2019-2024
• Cloud-based deployment - Market size and forecast 2019-2024
• Market opportunity by Deployment

Customer landscape

• Overview

Research Analysis Papermr. Becker's Classrooms

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• APAC - Market size and forecast 2019-2024
• South America - Market size and forecast 2019-2024
• MEA - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography

Drivers, Challenges, and Trends

• Market drivers
• Volume driver - Demand led growth
• Volume driver - Supply led growth
• Volume driver - External factors
• Volume driver - Demand shift in adjacent markets
• Price driver - Inflation
• Price driver - Shift from lower to higher priced units
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• APLAF Inc.
• Blackboard Inc.
• ClassDojo Inc.
• Dell Technologies Inc.
• Faronics Corp.
• HP Inc.
• Impero Solutions Ltd.
• Lenovo Group Ltd.
• Netop Solutions AS
• NetSupport Ltd.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Muscular Dystrophies article more useful, or one of our other health articles.

Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.

The muscular dystrophies (MDs) are a group of inherited disorders characterised by progressive muscle wasting and weakness. Becker's muscular dystrophy (BMD) is similar to the more common muscular dystrophy - Duchenne muscular dystrophy (DMD) - but the clinical course is milder. As with DMD, there is muscle wasting and weakness which is mainly proximal. Generally, walking difficulties begin after the age of 16.^[1]

Trending Articles

Female carriers of BMD may be affected, either by some degree of muscle weakness and/or by cardiomyopathy.

Epidemiology

The incidence is about 1 in 17,000 live births (about one fifth of DMD incidence).^[2] BMD is caused by abnormalities of the dystrophin gene, which is responsible for the muscle protein dystrophin. In BMD, abnormal but only partly functional dystrophin is produced (cf DMD, where dystrophin is lacking).

• It is inherited in an X-linked recessive pattern. There are various gene defects which give rise to BMD, affecting different parts of the dystrophin gene. The clinical severity of BMD varies and this is probably due to:
  • Variation in the individual genetic defects and hence in the dystrophins thus produced.
  • Factors other than the dystrophin gene, which determine the severity of BMD in an individual. In one reported family, two brothers with an identical gene defect had very different clinical manifestations of BMD.^[1]
• BMD can occur as a new mutation. Therefore, not all mothers of BMD patients will be carriers of the gene. BMD can also occur through mosaicism (where only some cell lines are affected).

Research Analysis Paper Mr. Becker's Classroom Solutions

Presentation^[2]

Symptoms

Symptoms usually begin in childhood. The average age at diagnosis is 11 years but there is a wide age range. The clinical severity varies.

Free download program cara menggunakan wga crack office 2016. Early symptoms

• Delayed walking (sometimes).
• Muscle cramps on exercise.
• Most BMD children are not 'athletic' and may struggle with school sports.

Later symptoms

• Muscle weakness:
  • Affects the proximal muscles of the limbs mainly.
  • May begin in teenage years or 20s, causing difficulty in climbing stairs, fast walking and lifting heavy objects.
• BMD patients can walk independently until the age of 16 or later (cf DMD, where patients cannot walk beyond the age of 12). Walking ability is lost (usually at the age of 40-60) but sometimes earlier, around the age of 20-30.

Signs

• Wasting of the proximal muscles; hypertrophy of others, particularly the calf muscles.

Other presentations

• Myoglobinuria.
• Anaesthetic complications - a dangerous, malignant hyperthermia-like reaction with some anaesthetic agents.
• Cardiomyopathy may be the first presentation, if muscle weakness is subclinical.
• There is a higher incidence of learning difficulties, behavioural problems and autistic spectrum disorders, compared with the general population.

Assessment

Investigations

Initial investigations

• Serum creatine kinase (CK) - shows moderate-severe increase in BMD (5-50 x normal levels).^[2]
• Raised CK levels in this scenario merit specialist referral for further investigation.

Further investigations

• Genetic analysis
• Muscle biopsy - for dystrophin staining
• Genetic tests and counselling for the family
• Monitoring for cardiomyopathy (see 'Cardiac complications', below).

Research Analysis Paper Mr. Becker's Classroom Management

Differential diagnosis

• Other muscular dystrophies: differentiation is by the clinical features such as age of onset and pattern of muscle weakness, by muscle biopsy features and by DNA analysis.
• Other myopathies - eg, thyrotoxicosis, Cushing's syndrome.
• Neurological causes of muscle weakness: spinal cord lesions, spinal muscular atrophy, motor neurone disease, multiple sclerosis. These conditions may have additional features such as sensory loss, upper motor neurone signs or muscle fasciculation.

Management

Treatment is supportive and includes:

• Exercise programmes and physiotherapy. Recent evidence suggests that exercise training is beneficial.^[3]
• Muscle cramps may be helped by night splints, massage or compression treatment using air-filled boots.
• Optimise nutrition:
  • Vitamin D and calcium for bone health.
  • Avoid obesity.
• After walking ability is lost - wheelchairs and other aids.
• Psychological support and employment advice.
• Monitoring/treatment of complications.

Complications and their management

Musculoskeletal complications

• Weakness can lead to joint contractures and scoliosis, which may require orthotic or orthopaedic treatment.
• Complications of immobility - eg, constipation and osteoporosis.

Cardiac complications^[4]

The severity of cardiomyopathy and congestive heart failure may not parallel the severity of skeletal muscle disease. Atrial and ventricular arrhythmias may be life-threatening. The degree of hypoventilation and pulmonary dysfunction also affects cardiac function in muscular dystrophy.^[5]

• Dilated cardiomyopathy:
  • Occurs in most BMD patients.^{[2, 6]}It is the main factor influencing survival.
  • May be the presenting feature, if muscle weakness is mild. The severity of cardiac involvement does not correlate with the severity of skeletal muscle weakness.^[7]
  • Asymptomatic (subclinical) cardiomyopathy is common.^[8]
  • Symptoms may be nonspecific - eg, fatigue, poor sleep, weight loss, vomiting.
• Arrhythmias.

Monitoring and treatment

• Regular cardiac monitoring from diagnosis/from age 10 years, including:
  • Clinical evaluation.
  • Electrocardiogram (ECG) and echocardiogram - these may be difficult to interpret due to scoliosis.
  • Other possible tests - cardiac MRI, multigated acquisition study (MUGA) and tissue Doppler echocardiography may be more helpful than standard echocardiography.^[9]
• Treatment is with standard regimens - eg, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers and diuretics for cardiac failure.
• Consider anticoagulation, as thromboembolism risk is increased.
• Nutrition and respiratory function should be optimised.
• Some patients require cardiac transplantation.^[6]

Anaesthetic complications^[4]

• Life-threatening rhabdomyolysis (malignant hyperthermia-type reaction) to some anaesthetic agents.
• Hyperkalaemia in response to succinylcholine.
• Higher risk of complications due to cardiac disease.
• Careful assessment and monitoring are required with any anaesthetic procedure or surgery.

Other complications

• Respiratory muscle weakness:
  • Depending on the clinical severity of muscle weakness, this is a possible complication. Management would be similar to that for DMD respiratory complications. See the separate Duchenne Muscular Dystrophy article.
• Pain in the lower back, spine and legs.^[10]

Prognosis

• Life expectancy is often reduced but there is a wide variation in severity and the prognosis can be excellent.
• Cardiomyopathy is the cause of death in about half of BMD patients.^[11]

Female carriers of Becker's muscular dystrophy

Cardiomyopathy risk

• Female carriers of the BMD gene may have an increased risk of cardiomyopathy.
• The extent of the risk is debatable; evidence is conflicting regarding rates of cardiomyopathy in carriers and regarding whether life expectancy is affected.^[12]
• An international workshop in 2002 recommended regular cardiac screening for BMD carriers.^[4]This recommendation has, however, been questioned.^[12]

Manifesting carriers^[2]

Research Analysis Paper Mr. Becker's Classroom Login

Most carriers are asymptomatic but a small percentage (2-5%) may have skeletal muscle symptoms; they are known as manifesting carriers of BMD:

• The reason why the gene manifests in some women but not in others may be through the mechanism of 'X-inactivation', where the normal X chromosome is inactive and the X chromosome carrying the BMD mutation is the active one.
• As with BMD boys, there may be no family history of the disease.
• Some cases of BMD manifesting carriers were previously diagnosed as having another type of muscular dystrophy but, with new techniques such as dystrophin staining, have been identified as having BMD.

Clinical features

• There is wide individual variation in the severity of symptoms - from mild muscle weakness, aches or calf muscle enlargement, to a disease as severe as that in boys.
• Onset of symptoms can be in adulthood.
• There is usually some gradual progression of symptoms with time.
• Cardiac involvement can occur.

Diagnosis

• Muscle biopsy looking at dystrophin is usually helpful.
• Genetic tests, including X-inactivation patterns.

Management, follow-up and prognosis
This varies depending on individual severity of symptoms.

Research Analysis Paper Mr. Becker's Classroom Assessment

See if you are eligible for a free NHS flu jab today.

1. Muscular Dystrophy, Becker Type, BMD; Online Mendelian Inheritance in Man (OMIM)

2. Manzur AY, Muntoni F; Diagnosis and new treatments in muscular dystrophies. J Neurol Neurosurg Psychiatry. 2009 Jul80(7):706-14.

3. Sveen ML, Jeppesen TD, Hauerslev S, et al; Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain. 2008 Nov131(Pt 11):2824-31. Epub 2008 Sep 6.

4. No authors listed; Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005 Dec116(6):1569-73.

5. Romfh A, McNally EM; Cardiac assessment in duchenne and becker muscular dystrophies. Curr Heart Fail Rep. 2010 Dec7(4):212-8. doi: 10.1007/s11897-010-0028-2.

6. Connuck DM, Sleeper LA, Colan SD, et al; Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2008 Jun155(6):998-1005. Epub 2008 Mar 19.

7. Finsterer J, Stollberger C; Cardiac involvement in Becker muscular dystrophy. Can J Cardiol. 2008 Oct24(10):786-92.

8. Sultan A, Fayaz M; Prevalence of cardiomyopathy in Duchenne and Becker's muscular dystrophy. J Ayub Med Coll Abbottabad. 2008 Apr-Jun20(2):7-13.

9. Meune C, Pascal O, Becane HM, et al; Reliable detection of early myocardial dysfunction by tissue Doppler echocardiography in Becker muscular dystrophy. Heart. 2004 Aug90(8):947-8.

10. Zebracki K, Drotar D; Pain and activity limitations in children with Duchenne or Becker muscular dystrophy. Dev Med Child Neurol. 2008 Jul50(7):546-52.

11. Finsterer J, Stollberger C; The heart in human dystrophinopathies. Cardiology. 200399(1):1-19.

12. Holloway SM, Wilcox DE, Wilcox A, et al; Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart. 2007 Oct 11

My symptoms are below:-Mid 2006- Felt right leg week when I am exercising. Felt right hand weak and fine tremor.-Did all possible tests and MRI,EMG, everything normal in 2008.-2006-2017 - I let it go..

Feeling unwell?

Assess your symptoms online with our free symptom checker.